NASDAQ:SOPH SOPHiA GENETICS Q3 2026 Earnings Report $7.15 -0.23 (-3.12%) Closing price 10/7/2026 04:00 PM EasternExtended Trading$7.13 -0.02 (-0.28%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast SOPHiA GENETICS EPS ResultsActual EPSN/AConsensus EPS -$0.20Beat/MissN/AOne Year Ago EPSN/ASOPHiA GENETICS Revenue ResultsActual RevenueN/AExpected Revenue$24.03 millionBeat/MissN/AYoY Revenue GrowthN/ASOPHiA GENETICS Announcement DetailsQuarterQ3 2026Date11/3/2026TimeBefore Market OpensConference Call DateTuesday, November 3, 2026Conference Call Time8:00AM ETConference Call ResourcesEarnings HistoryCompany Profile SOPHiA GENETICS Earnings HeadlinesSOPHiA GENETICS SA (NASDAQ:SOPH) Stock Has Consensus Target Price of $10.00 According to BrokeragesOctober 6 at 6:15 AM | americanbankingnews.comCritical Comparison: Weave Communications (NYSE:WEAV) vs. SOPHiA GENETICS (NASDAQ:SOPH)October 6 at 2:15 AM | americanbankingnews.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | Porter & Company (Ad)SOPHiA GENETICS SA (SOPH)September 18, 2026 | finance.yahoo.comSOPHiA Genetics: Scaling Phase Begins As U.S. And Pharma Monetization InflectSeptember 16, 2026 | seekingalpha.comSOPHiA GENETICS (SOPH) Q2 2026 Earnings Call TranscriptAugust 11, 2026 | finance.yahoo.comSee More SOPHiA GENETICS Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like SOPHiA GENETICS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SOPHiA GENETICS and other key companies, straight to your email. Email Address About SOPHiA GENETICSSOPHiA GENETICS (NASDAQ:SOPH) is a healthcare technology company that develops cloud-based data analytics solutions for the life sciences and healthcare industries. Its platform is designed to help organizations analyze and interpret complex genomic and multimodal data to support more informed clinical and research decisions. The company’s principal offering, the SOPHiA DDM platform, combines data management, analytics and artificial intelligence capabilities. It supports applications including cancer genomics, hereditary disease analysis, reproductive health and other areas of precision medicine. The platform is intended to help laboratories and clinical teams standardize workflows, interpret test results and share insights across institutions. Founded in 2011 and headquartered in Switzerland, SOPHiA GENETICS serves hospitals, laboratories, academic institutions and pharmaceutical companies in multiple international markets. Its technology is used to support clinical diagnostics, translational research and drug development, with an emphasis on enabling collaboration and the broader adoption of data-driven healthcare.View SOPHiA GENETICS ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Skydance Just Became a Media Giant—With an $80 Billion Debt LoadPenguin Solutions Is Soaring as AI Memory Demand ExplodesWall Street Is Betting These 3 Beaten-Down Stocks Have More Room to RunLamb Weston’s Turnaround Is Starting to Look RealRPM International’s Dividend King Status Just Got StrongerAI Chip Demand Gives Linde a New Growth CatalystAllient’s Data Center and Defense Momentum Is Raising the Stakes Upcoming Earnings Delta Air Lines (10/9/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
